Literature DB >> 19086911

Weight increase is associated with skeletal muscle immunostaining for advanced glycation end products, receptor for advanced glycation end products, and oxidation injury.

Maria Pia de la Maza1, Jaime Uribarri, Daniela Olivares, Sandra Hirsch, Laura Leiva, Gladys Barrera, Daniel Bunout.   

Abstract

BACKGROUND: Tissue accumulation of advanced glycation end products (AGEs) is associated with ageing, both in diabetics and nondiabetic subjects. AIM: The purpose of this study was to assess immunostaining for AGEs, specifically carboxymethyl-lysine (CML) and receptor for AGEs (RAGE), in muscle tissue of healthy male subjects differing in age and weight stability.
METHODOLOGY: Muscle tissue was obtained during hernia surgery in middle-aged men reporting weight maintenance (WM, n = 10) or weight gain (WG, n = 7), and also in 4 elderly men. Tissue inmunostaining for CML and RAGE was performed.
RESULTS: Intensity of CML and RAGE staining were highly correlated (r = 0.84) and also significantly associated with weight change and age. Muscle AGEs accretion was statistically associated with muscle expression of oxidative injury (8-hydroxy-deoxyguanosine and 4-hydroxy-2-nonenal) and inflammatory markers (tumor necrosis factor-alpha). DISCUSSION: The increase of skeletal muscle AGEs/RAGE and markers of inflammation and oxidative injury in association with weight gain and old age suggest a pathogenic role of AGEs in weight gain and in sarcopenia of aging.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19086911     DOI: 10.1089/rej.2008.0786

Source DB:  PubMed          Journal:  Rejuvenation Res        ISSN: 1549-1684            Impact factor:   4.663


  13 in total

1.  Skeletal muscle ceramide species in men with abdominal obesity.

Authors:  M P de la Maza; J M Rodriguez; S Hirsch; L Leiva; G Barrera; D Bunout
Journal:  J Nutr Health Aging       Date:  2015-04       Impact factor: 4.075

2.  Morphological adaptation of muscle collagen and receptor of advanced glycation end product (RAGE) in osteoarthritis patients with 12 weeks of resistance training: influence of anti-inflammatory or glucosamine treatment.

Authors:  Ana Claudia Mattiello-Sverzut; Susanne G Petersen; Michael Kjaer; Abigail L Mackey
Journal:  Rheumatol Int       Date:  2013-02-27       Impact factor: 2.631

3.  Relationship of an advanced glycation end product, plasma carboxymethyl-lysine, with slow walking speed in older adults: the InCHIANTI study.

Authors:  Richard D Semba; Stefania Bandinelli; Kai Sun; Jack M Guralnik; Luigi Ferrucci
Journal:  Eur J Appl Physiol       Date:  2009-09-16       Impact factor: 3.078

4.  Atorvastatin inhibits the expression of RAGE induced by advanced glycation end products on aortas in healthy Sprague-Dawley rats.

Authors:  Lei Xu; Panpan Zang; Bo Feng; Qiaohui Qian
Journal:  Diabetol Metab Syndr       Date:  2014-09-23       Impact factor: 3.320

Review 5.  The Contribution of Advanced Glycation End product (AGE) accumulation to the decline in motor function.

Authors:  Hans Drenth; Sytse Zuidema; Steven Bunt; Ivan Bautmans; Cees van der Schans; Hans Hobbelen
Journal:  Eur Rev Aging Phys Act       Date:  2016-03-04       Impact factor: 3.878

6.  The Association Between Variants of Receptor for Advanced Glycation End Products (RAGE) Gene Polymorphisms and Age-Related Macular Degeneration.

Authors:  Mantas Banevicius; Alvita Vilkeviciute; Loresa Kriauciuniene; Rasa Liutkeviciene; Vytenis Pranas Deltuva
Journal:  Med Sci Monit       Date:  2018-01-10

7.  Association of accumulated advanced glycation end-products with a high prevalence of sarcopenia and dynapenia in patients with type 2 diabetes.

Authors:  Hiroyasu Mori; Akio Kuroda; Masashi Ishizu; Mami Ohishi; Yuichi Takashi; Yinhua Otsuka; Satoshi Taniguchi; Motoyuki Tamaki; Kiyoe Kurahashi; Sumiko Yoshida; Itsuro Endo; Ken-Ichi Aihara; Makoto Funaki; Yuko Akehi; Munehide Matsuhisa
Journal:  J Diabetes Investig       Date:  2019-02-19       Impact factor: 4.232

Review 8.  Advanced glycation end-products: modifiable environmental factors profoundly mediate insulin resistance.

Authors:  Mona S Ottum; Anahita M Mistry
Journal:  J Clin Biochem Nutr       Date:  2015-07-01       Impact factor: 3.114

Review 9.  Role of advanced glycation end products in mobility and considerations in possible dietary and nutritional intervention strategies.

Authors:  Jie-Hua Chen; Xu Lin; Cuihong Bu; Xuguang Zhang
Journal:  Nutr Metab (Lond)       Date:  2018-10-10       Impact factor: 4.169

Review 10.  RAGE in the pathophysiology of skeletal muscle.

Authors:  Francesca Riuzzi; Guglielmo Sorci; Roberta Sagheddu; Sara Chiappalupi; Laura Salvadori; Rosario Donato
Journal:  J Cachexia Sarcopenia Muscle       Date:  2018-10-18       Impact factor: 12.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.